Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Experts call for significant changes to facilitate the discovery of new treatments.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.

Inspired by her mother, Vicky Qi leads drug discovery teams.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

Novartis researcher Joana Silva had a life-changing experience with a mentor.